Based in San Francisco and Palo Alto, Joanne Yun leads Egon Zehnder’s San Francisco office and is a member of Egon Zehnder’s Health Practice. In addition to her board and commercial work for global pharmaceutical and biotechnology companies, Joanne leads the Research & Development segment of the Health Practice. She is passionate about serving the oncology sector and supporting academic leaders who are transitioning into senior industry roles.
Prior to joining Egon Zehnder, Joanne served as a director in the Global Oncology Business Unit for Bayer HealthCare Pharmaceuticals with responsibility for oncology-program management and new product planning. She advised on all aspects of research, development, and commercial strategy, including portfolio prioritization, business development, alliance governance, and merger integration. Joanne started her career with Bayer AG as a Bench Chemist and Laboratory Head in the Organic Synthesis Department of Bayer’s Central Research Division in Leverkusen, Germany. She later transitioned into the Corporate R&D Planning Department for the Bayer Board of Management and was promoted to Manager in the Strategic Planning Department, where she focused on global merger & acquisition strategies and transactions. Joanne subsequently transferred to Bayer Corporation in West Haven, Connecticut, where she was a Senior Manager in Bayer Healthcare’s North America Business Development & Licensing group.
Joanne earned a BA in chemistry and French from Amherst College and a PhD in chemistry from MIT. She was a NIH/NCI Postdoctoral Fellow at the Scripps Research Institute. Joanne is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Chemical Society, and the Licensing Executives Society.